Diagnamed Holdings Corp. DMED
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 76.82% | 4.69% | -27.77% | 322.85% | 691.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.04% | -49.89% | -43.00% | 296.58% | 312.96% |
| Operating Income | -70.04% | 49.89% | 43.00% | -296.58% | -312.96% |
| Income Before Tax | -106.96% | 43.73% | 35.21% | -137.18% | -154.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.96% | 43.73% | 35.21% | -137.18% | -154.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.96% | 43.73% | 35.21% | -137.18% | -154.90% |
| EBIT | -70.04% | 49.89% | 43.00% | -296.58% | -312.96% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -80.49% | 60.00% | 58.33% | -72.22% | -105.00% |
| Normalized Basic EPS | -58.62% | 58.33% | 57.14% | -122.22% | -123.08% |
| EPS Diluted | -80.49% | 60.00% | 58.33% | -94.44% | -105.00% |
| Normalized Diluted EPS | -58.62% | 58.33% | 57.14% | -122.22% | -123.08% |
| Average Basic Shares Outstanding | 16.10% | 38.73% | 42.11% | 34.31% | 24.06% |
| Average Diluted Shares Outstanding | 16.10% | 38.73% | 42.11% | 34.31% | 24.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |